Hypertension. 2003;41:437-445
Published online before print February 10, 2003, doi: 10.1161/01.HYP.0000054981.03589.E9
Published online before print February 10, 2003, doi: 10.1161/01.HYP.0000054981.03589.E9
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2003;41:437.)
© 2003 American Heart Association, Inc.
Scientific Contributions |
Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy
From the Department of Obstetrics, Gynecology and Reproductive Sciences, Graduate School of Public Health, University of Pittsburgh, and Magee-Womens Research Institute (J.M.R.), Pittsburgh, Pa; Heart Development, Function and Failure Scientific Research Group, Division of Heart and Vascular Disease (G.D.P.), and Division of Epidemiology and Clinical Applications (J.A.C.), National Heart, Lung, and Blood Institute/National Institutes of Health, Bethesda, Md; and Department of Obstetrics & Gynecology and Medicine, Division of Biological Sciences, The Pritzker School of Medicine (M.D.L.), University of Chicago, Ill.
Correspondence to James M. Roberts, MD, 204 Craft Avenue, Suite 610, Pittsburgh, PA 15213. E-mail rsijmr{at}mail.magee.edu
A Working Group on Research in Hypertension in Pregnancy was recently convened by the National Heart, Lung, and Blood Institute to determine the state of knowledge in this area and suggest appropriate directions for research. Hypertensive disorders in pregnancy, especially preeclampsia, are a leading cause of maternal death worldwide and even in developed countries increase perinatal mortality rates 5-fold. Much has been learned about preeclampsia, but gaps in the knowledge necessary to direct therapeutic strategies remain. Oxidative stress is a biologically plausible contributor to the disorder that may be amenable to intervention. Hypertension that antedates pregnancy (chronic hypertension) bears many similarities to hypertension in nonpregnant women, but the special setting of pregnancy demands information to guide evidence-based therapy. The recommendations of the Working Group are to attempt a clinical trial of antioxidant therapy to prevent preeclampsia that is be complemented by mechanistic research to increase understanding of the genetics and pathogenesis of the disorder. For chronic hypertension, clinical trials are recommended to direct choice of drugs, evaluate degree of control, and assess implications to the mother and fetus. Recommendations to increase participation in this research are also presented.
Key Words: hypertension, pregnancy • preeclampsia • pregnancy • research • oxidative stress • mortality
This article has been cited by other articles:
 |
|
 |
|
  V. Ehrenstein, K. J. Rothman, L. Pedersen, E. E. Hatch, and H. T. Sorensen Pregnancy-associated Hypertensive Disorders and Adult Cognitive Function Among Danish Conscripts Am. J. Epidemiol., October 15, 2009; 170(8): 1025 - 1031. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. LaMarca, M. Parrish, L. F. Ray, S. R. Murphy, L. Roberts, P. Glover, G. Wallukat, K. Wenzel, K. Cockrell, J. N. Martin Jr, et al. Hypertension in Response to Autoantibodies to the Angiotensin II Type I Receptor (AT1-AA) in Pregnant Rats: Role of Endothelin-1 Hypertension, October 1, 2009; 54(4): 905 - 909. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Hultin, P. Hellman, E. Lundgren, M. Olovsson, A. Ekbom, J. Rastad, and S. M. Montgomery Association of Parathyroid Adenoma and Pregnancy with Preeclampsia J. Clin. Endocrinol. Metab., September 1, 2009; 94(9): 3394 - 3399. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Catov, E. A. Nohr, L. M. Bodnar, V. K. Knudson, S. F. Olsen, and J. Olsen Association of Periconceptional Multivitamin Use With Reduced Risk of Preeclampsia Among Normal-Weight Women in the Danish National Birth Cohort Am. J. Epidemiol., June 1, 2009; 169(11): 1304 - 1311. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Humphrey and J. S. Tucker Rising rates of obstetric interventions: exploring the determinants of induction of labour J. Public Health Med., March 1, 2009; 31(1): 88 - 94. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Fitzpatrick, M.P. Johnson, T.D. Dyer, S. Forrest, K. Elliott, J. Blangero, S.P. Brennecke, and E.K. Moses Genetic association of the activin A receptor gene (ACVR2A) and pre-eclampsia Mol. Hum. Reprod., March 1, 2009; 15(3): 195 - 204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Stennett, X. Qiao, A. E. Falone, V. V. Koledova, and R. A. Khalil Increased vascular angiotensin type 2 receptor expression and NOS-mediated mechanisms of vascular relaxation in pregnant rats Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H745 - H755. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Hawfield and B. I. Freedman Pre-eclampsia: the pivotal role of the placenta in its pathophysiology and markers for early detection Therapeutic Advances in Cardiovascular Disease, February 1, 2009; 3(1): 65 - 73. [Abstract] [PDF]
|
|
|
|
|
|
J. S. Gilbert, S. A.B. Gilbert, M. Arany, and J. P. Granger Hypertension Produced by Placental Ischemia in Pregnant Rats Is Associated With Increased Soluble Endoglin Expression Hypertension, February 1, 2009; 53(2): 399 - 403. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Leeners, R. Stiller, P. Neumaier-Wagner, S. Kuse, A. Schmitt, and W. Rath Psychosocial Distress Associated With Treatment of Hypertensive Diseases in Pregnancy Psychosomatics, September 1, 2008; 49(5): 413 - 419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. D. LaMarca, J. Gilbert, and J. P. Granger Recent Progress Toward the Understanding of the Pathophysiology of Hypertension During Preeclampsia Hypertension, April 1, 2008; 51(4): 982 - 988. [Full Text] [PDF]
|
|
|
|
|
|
M. J. Cipolla, J. Smith, N. Bishop, L. V. Bullinger, and J. A. Godfrey Pregnancy Reverses Hypertensive Remodeling of Cerebral Arteries Hypertension, April 1, 2008; 51(4): 1052 - 1057. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Gilbert, M. J. Ryan, B. B. LaMarca, M. Sedeek, S. R. Murphy, and J. P. Granger Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H541 - H550. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Hering, F. Herse, S. Verlohren, J.-K. Park, M. Wellner, F. Qadri, R. Pijnenborg, A. C. Staff, B. Huppertz, D. N. Muller, et al. Trophoblasts Reduce the Vascular Smooth Muscle Cell Proatherogenic Response Hypertension, February 1, 2008; 51(2): 554 - 559. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Gilbert, S. A. Babcock, and J. P. Granger Hypertension Produced by Reduced Uterine Perfusion in Pregnant Rats Is Associated With Increased Soluble Fms-Like Tyrosine Kinase-1 Expression Hypertension, December 1, 2007; 50(6): 1142 - 1147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Sholook, J. S. Gilbert, M. H. Sedeek, M. Huang, R. L. Hester, and J. P. Granger Systemic hemodynamic and regional blood flow changes in response to chronic reductions in uterine perfusion pressure in pregnant rats Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2080 - H2084. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Rajakumar, A. Jeyabalan, N. Markovic, R. Ness, C. Gilmour, and K. P. Conrad Placental HIF-1{alpha}, HIF-2{alpha}, membrane and soluble VEGF receptor-1 proteins are not increased in normotensive pregnancies complicated by late-onset intrauterine growth restriction Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2007; 293(2): R766 - R774. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.S. Knox and J.C. Baker Genome-wide expression profiling of placentas in the p57Kip2 model of pre-eclampsia Mol. Hum. Reprod., April 1, 2007; 13(4): 251 - 263. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M Catov, R. B Ness, K. E Kip, and J. Olsen Risk of early or severe preeclampsia related to pre-existing conditions Int. J. Epidemiol., April 1, 2007; 36(2): 412 - 419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Maduwegedera, M. M. Kett, R. L. Flower, G. W. Lambert, J. F. Bertram, E. M. Wintour, and K. M. Denton Sex differences in postnatal growth and renal development in offspring of rabbit mothers with chronic secondary hypertension Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R706 - R714. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Gadonski, B. B. D. LaMarca, E. Sullivan, W. Bennett, D. Chandler, and J. P. Granger Hypertension Produced by Reductions in Uterine Perfusion in the Pregnant Rat: Role of Interleukin 6 Hypertension, October 1, 2006; 48(4): 711 - 716. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Anderson, F. Lopez, A. Zimmer, and J. N. Benoit Placental Insufficiency Leads to Developmental Hypertension and Mesenteric Artery Dysfunction in Two Generations of Sprague-Dawley Rat Offspring Biol Reprod, March 1, 2006; 74(3): 538 - 544. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Roberts, B. B. D. LaMarca, L. Fournier, J. Bain, K. Cockrell, and J. P. Granger Enhanced Endothelin Synthesis by Endothelial Cells Exposed to Sera From Pregnant Rats With Decreased Uterine Perfusion Hypertension, March 1, 2006; 47(3): 615 - 618. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Roberts and H. S. Gammill Preeclampsia: Recent Insights Hypertension, December 1, 2005; 46(6): 1243 - 1249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Khan, J. J.F. Belch, M. MacLeod, and G. Mires Changes in Endothelial Function Precede the Clinical Disease in Women in Whom Preeclampsia Develops Hypertension, November 1, 2005; 46(5): 1123 - 1128. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. T. Merchant, G. Msamanga, E. Villamor, E. Saathoff, M. O'Brien, E. Hertzmark, D. J. Hunter, and W. W. Fawzi Multivitamin Supplementation of HIV-Positive Women during Pregnancy Reduces Hypertension J. Nutr., July 1, 2005; 135(7): 1776 - 1781. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. O Scholl, M. Leskiw, X. Chen, M. Sims, and T P. Stein Oxidative stress, diet, and the etiology of preeclampsia Am. J. Clinical Nutrition, June 1, 2005; 81(6): 1390 - 1396. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. Euser and M. J. Cipolla Resistance artery vasodilation to magnesium sulfate during pregnancy and the postpartum state Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1521 - H1525. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.-X. Yi, R. R. Magness, and I. M. Bird Simultaneous imaging of [Ca2+]i and intracellular NO production in freshly isolated uterine artery endothelial cells: effects of ovarian cycle and pregnancy Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2005; 288(1): R140 - R148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Orshal and R. A. Khalil Interleukin-6 impairs endothelium-dependent NO-cGMP-mediated relaxation and enhances contraction in systemic vessels of pregnant rats Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2004; 286(6): R1013 - R1023. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Cipolla, L. Vitullo, and J. McKinnon Cerebral artery reactivity changes during pregnancy and the postpartum period: a role in eclampsia? Am J Physiol Heart Circ Physiol, June 1, 2004; 286(6): H2127 - H2132. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Orshal and R. A. Khalil Reduced Endothelial NO-cGMP-Mediated Vascular Relaxation and Hypertension in IL-6-Infused Pregnant Rats Hypertension, February 1, 2004; 43(2): 434 - 444. [Abstract] [Full Text] [PDF]
|
|